The Jak1/Jak2 Inhibitor Momelotinib Inhibits Alk2, Decreases Hepcidin Production and Ameliorates Anemia of Chronic Disease (ACD) in Rodents

被引：7
|
作者：
Asshoff, Malte [1 ]
Warr, Matthew [2 ]
Haschka, David [1 ]
Tymoszuk, Piotr [1 ]
Petzer, Verena [1 ]
Demetz, Egon [1 ]
Maciejewski, Pat [2 ]
Seifert, Markus [1 ]
Nairz, Manfred [1 ]
Posch, Wilfried [3 ]
Fowles, Peter [2 ]
Weiss, Guenter [1 ]
Whitney, Andy [2 ]
Theurl, Igor [1 ]
机构：
[1] Med Univ Innsbruck, Internal Med 6, A-6020 Innsbruck, Austria
[2] Gilead Sci, Branford, CT USA
[3] Med Univ Innsbruck, Divsison Hyg & Med Microbiol, A-6020 Innsbruck, Austria
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.538.538
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
    Asshoff, Malte
    Petzer, Verena
    Warr, Matthew R.
    Haschka, David
    Tymoszuk, Piotr
    Demetz, Egon
    Seifert, Markus
    Posch, Wilfried
    Nairz, Manfred
    Maciejewski, Pat
    Fowles, Peter
    Burns, Christopher J.
    Smith, Gregg
    Wagner, Kay-Uwe
    Weiss, Guenter
    Whitney, J. Andrew
    Theurl, Igor
    BLOOD, 2017, 129 (13) : 1823 - 1830
  • [2] ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
    Oh, Stephen T.
    Talpaz, Moshe
    Gerds, Aaron T.
    Gupta, Vikas
    Verstovsek, Srdan
    Mesa, Ruben
    Miller, Carole B.
    Rivera, Candido E.
    Fleischman, Angela G.
    Goel, Swati
    Heaney, Mark L.
    O'Connell, Casey
    Arcasoy, Murat O.
    Zhang, Yafeng
    Kawashima, Jun
    Ganz, Tomas
    Kowalski, Mark
    Brachmann, Carrie Baker
    BLOOD ADVANCES, 2020, 4 (18) : 4282 - 4291
  • [3] MOMELOTINIB HYDROCHLORIDE JAK1/JAK2 inhibitor Treatment of myelofibrosis Treatment of pancreatic cancer
    Price, S.
    George, T.
    Pinilla-Ibarz, J.
    DRUGS OF THE FUTURE, 2015, 40 (09) : 561 - 568
  • [4] Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia
    Winton, Elliott F.
    Kota, Vamsi
    FUTURE ONCOLOGY, 2017, 13 (05) : 395 - 407
  • [5] Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis
    A Pardanani
    J Gotlib
    A W Roberts
    M Wadleigh
    S Sirhan
    J Kawashima
    J A Maltzman
    L Shao
    V Gupta
    A Tefferi
    Leukemia, 2018, 32 : 1034 - 1037
  • [6] Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis
    Pardanani, A.
    Gotlib, J.
    Roberts, A. W.
    Wadleigh, M.
    Sirhan, S.
    Kawashima, J.
    Maltzman, J. A.
    Shao, L.
    Gupta, V.
    Tefferi, A.
    LEUKEMIA, 2018, 32 (04) : 1034 - 1037
  • [7] A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
    Verstovsek, Srdan
    Courby, Stephane
    Griesshammer, Martin
    Mesa, Ruben A.
    Brachmann, Carrie Baker
    Kawashima, Jun
    Maltzman, Julia D.
    Shao, Lixin
    Xin, Yan
    Huang, Daniel
    Bajel, Ashish
    LEUKEMIA RESEARCH, 2017, 60 : 11 - 17
  • [8] Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis
    Pardanani, Animesh
    Gotlib, Jason
    Gupta, Vikas
    Roberts, Andrew W.
    Wadleigh, Martha
    Sirhan, Shireen
    Bavisotto, Linda M.
    Kawashima, Jun
    Lee, Peter
    Kowalski, Mark
    Deng, Wei
    Niforos, Demi
    Tefferi, Ayalew
    BLOOD, 2013, 122 (21)
  • [9] Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis
    Vaddi, Kris
    Sarlis, Nicholas J.
    Gupta, Vikas
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (16) : 2397 - 2407
  • [10] ALK2 and JAK2 Inhibition for Improved Treatment of Anemia in Myelofibrosis Patients: Preclinical Profile of an ALK2 Inhibitor Zilurgisertib in Combination with Ruxolitinib
    Stubbs, Matthew C.
    Pusey, Michelle
    Wen, Xiaoming
    Drake, Katherine
    Zolotarjova, Nina
    Smith, Amanda
    Covington, Maryanne
    Zhang, Guofeng
    Macarron, Ricardo
    Kim, Sunkyu
    BLOOD, 2023, 142
12345